A Decade of Nintedanib: An Analysis of the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Niranjan, S. [1 ]
Rao, A. [2 ]
Virk, S. T. [1 ]
Sarangdhar, M. [3 ]
机构：
[1] Allegheny Gen Hosp, Internal Med, Pittsburgh, PA USA
[2] Carnegie Mellon Univ, Quantitat Biol & Bioinformat, Pittsburgh, PA USA
[3] Univ Cincinnati, Biomed Informat, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3746
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database
    Yang, Haiyan
    Wan, Zheng
    Chen, Moliang
    Zhang, Xiaohong
    Cui, Wugeng
    Zhao, Bin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 217 - 223
  • [32] Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database
    Shuai, Yichun
    Chen, Zhe
    Wan, Qiaoqian
    Wu, Jinzheng
    Wang, Xin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”
    Rashid Kazerooni
    Edward P. Armstrong
    Clinical Drug Investigation, 2018, 38 : 1199 - 1200
  • [34] Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database
    Yang, Xiuli
    Zheng, Xiaochun
    Zhang, Miaomiao
    Huang, Jinlong
    Huang, Ping
    Wang, Jiangfeng
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 617 - 630
  • [35] Hypercalcemia in children induced by denosumab: a case report and an analysis of the FDA adverse event reporting system database
    Chen, Yiyu
    Fang, Chuxuan
    Yang, Zhiyong
    Qiu, Guosheng
    Tang, Shuangyi
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [36] Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database
    Han, Weiru
    Morris, Robert
    Bu, Kun
    Zhu, Tianrui
    Huang, Hong
    Cheng, Feng
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2025, 103 (02) : 56 - 69
  • [37] A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
    Liu, Liyuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
    Stamoula, Eleni
    Stamatellos, Vasileios-Periklis
    Vavilis, Theofanis
    Dardalas, Ioannis
    Papazisis, Georgios
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (02) : 239 - 245
  • [39] Response to "Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database"
    Kazerooni, Rashid
    Armstrong, Edward P.
    CLINICAL DRUG INVESTIGATION, 2018, 38 (12) : 1199 - 1200
  • [40] Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database
    Andrews, Michael B.
    Adler, Douglas G.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (07) : 389 - 395
12345